Reach Fertility has an experienced research division solely dedicated to conducting clinical research trials. Our research has been published in leading fertility journals and contributed to advancements in the field of Reproductive Endocrinology. Clinical research trial participants may qualify to receive low-cost or no-cost fertility treatment. We currently have 2 research studies open for enrollment: The Progress Study and The Rebalance Study. More info below.
Learn more about this clinical trial here--->>>The PROGRESS Study
Reach Fertility is currently one of only 17 sites across the US approved to offer patients an opportunity to participate in THE PROGRESS STUDY. This study does not change the way we do treatment at Reach, but is simply a comparison of the efficiency of administering medicine during a normal treatment cycle.
To participate in this clinical study you must meet the following criteria:
- Are between 35 to 42 years old
- Have a BMI of <38 kg/m2
- Have regular menstrual cycle of 24 to 38 days
- Do not have history of recurrent pregnancy loss __________________________________________________________________________
The investigational REBALANCE Study is currently recruiting patients. Learn More about this PCOS study HERE
Women diagnosed with PCOS-related infertility and meeting the REBALANCE Study’s entry criteria may be eligible. Key entry criteria are women who:- Are between 18 to 40 years old.
- Are experiencing anovulatory infertility due to PCOS.
- Have a BMI < 40.
- Have had no clinical response to ovulation induction treatment such as letrozole or clomiphene citrate or are contraindicated for or decline such treatment.
- Are currently seeking immediate fertility.
Complete the info box below if you are interested in qualifying for either of these programs.
Please contact callcenter@northcarolinafertility.com
Contact our team to get started at 704-343-4444
FOR MORE INFORMATION ABOUT ENROLLING IN A CLINICAL RESEARCH TRIAL, PLEASE SUBMIT THE FORM BELOW.
